November 11, 2025 8:39am

A 2-finger tip of the eye or hat with a short version to remember those, the more than a few who gave their life, limbs and mental strength for the many

And pass the bill … To end the shutdown, the House needs to pass the Senate bill, and then President Trump can sign it into law

Never leave an investor uninformed … I say what others won’t, so you can do what others can’t!

 

A short version to remember those, the more than a few who gave their life, limbs and mental strength for the many

RMi Closing Bell: Almost Open … https://www.regmedinvestors.com/articles/14189

Remember that overnight and pre-open actions’ futures and markets doesn’t necessarily translate into actual trading in today’s market session.

 

Tuesday: The pre-open Dow futures are DOWN -0.01% or (-1 points), the S&P futures are DOWN -0.29% or (-20 points) and the Nasdaq futures are DOWN -0.53% or (-137 points)

  • Stock futures ticked mixed and lower
  • European markets rose
  • Asia Pacific markets lost most gains

 

Henry’omics: We need to more than consider the market’s setting to grasp the micro re “our” universe of cell and gene therapy companies

  • Monday: The Dow closed UP +381.53 points or +0.81%, the S&P closed UP +103.63 points or +1.54% while the Nasdaq closed UP +522.637 points or +2.27%
  • Friday: The Dow closed UP +74.80 points or +0.16%, the S&P closed UP +8.48 points or +0.13% while the Nasdaq closed DOWN -49.455 points or -0.22%
  • Last week: The S&P 500 was down -1.7%, the Dow -1.3% and the Nasdaq -3%
  • The previous week: The S&P 500 was up 1.5%, the Dow +0.9% and the Nasdaq is up +3.2%
  • Last month: the S&P 500 was up +2.3%, the Nasdaq’s +4.7% and the Dow’s is up +2.5%.

 

Q4 – November, 2 positive and 4 negative sessions

  • October, 1 neutral, 10 positive and 12 negative closes
  • Q3 – September, 1 holiday, 9 negative and 12 positive closes; August - 11 negative and 9 positive closes; July – 1 market holiday, 13 positive and 9 negative closes

Companies in my headlights – It’s your decision; I provide ideas and context

I post about “indication intelligence” looking toward investment conferences … to assist investors with insight into sector vulnerabilities and strengths.  A dictionary definition of “indicate” refers to something less than a certainty; an indication could be a signal of being oversold or overbought, a recommendation, or grounds for inferring or a basis for believing.

A short version this a.m.

 

The BOTTOM LINE: Still feeling the what … uncertainty!

The 7th trading day of November followed a positive close.

I got on my computer/laptop/ my horse with a lantern as I ride yelling … “earnings are here, earnings are here”!

  • Q3 Earnings coming: Arrowhead Pharma (ARWR) FY25 results on 11/25

Expect earnings’ results that meet, beat or miss revenue estimates, EPS as to pricing expectations, consensus … sector earnings while LPS (loss-per-share) assumes adjustments

Welcome to my world of defining the “grey’ in our universe!

  • As the leading voice of cell and gene therapy investors; I am NOT always a doom and gloom analyst/journalist but a man who has been “there” (BUY, SELL, VC and multiple operating roles) with the gray hair and a readership following with real numbers to prove it!
  • I am more frequently right than consequentially wrong; if I wanted to be liked, I wouldn’t have been an analyst/journalist.

 

November to understand the flow:

This week:

  • 11/10 - Monday closed positive with 26 positive, 14 negative and 0 flats

Last week:

  • 11/7 – Friday closed negative with 16 positive, 24 negative and 0 flat
  • 11/6 – Thursday closed negative with 15 positive, 24 negative and 1 flat
  • 11/5 - Wednesday closed positive with 20 positive, 18 negative and 2 flats
  • 11/4 – Tuesday closed negative with 10 positive, 30 negative and 0 flat
  • 11/3 – Monday closed negative with 10 positive, 26 negative and 4 flats

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice. All investments are subject to risks. Investors should consider investment objectives.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.  Regulation Analyst Certification (Reg AC):

The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and it’s or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed.